Table 2.
Characteristic | OS, p-value | RFS, p-value |
---|---|---|
Age (≥ 70 vs. < 70) | 0.062 | 0.132 |
Race (Caucasian vs. other) | 0.716 | 0.388 |
Obese (BMI ≥ 30 vs. < 30) | 0.249 | 0.281 |
Smoking history | 0.008 | 0.076 |
Oral contraceptive history | 0.634 | 0.182 |
History of hormone replacement therapy | 0.575 | 0.226 |
Family history of cancer | 0.502 | 0.579 |
Histology (pure USC vs. mixed) | 0.168 | 0.551 |
Endocervical glandular involvement | 0.530 | 0.278 |
Endocervical stromal involvement | 0.450 | 0.768 |
Myometrial invasion (≥ 50% vs. < 50%) | 0.001 | < 0.0001 |
Lymph-vascular space invasion | 0.971 | 0.003 |
Lower uterine segment involvement | 0.388 | 0.551 |
Cytology positive | 0.716 | 0.587 |